Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET

Detecting tumor lesions <1 cm in size using current imaging methods remains a clinical challenge, especially in pancreatic cancer. Previously, we developed a method to identify pancreatic tumor lesions ≥3 mm using positron emission tomography (PET) with an intraperitoneally administered (64)Cu-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiroki, Igarashi, Chika, Tachibana, Tomoko, Hihara, Fukiko, Shinada, Mitsuhiro, Waki, Atsuo, Yoshida, Sei, Naito, Kenichiro, Kurihara, Hiroaki, Ueno, Makoto, Ito, Kimiteru, Higashi, Tatsuya, Yoshii, Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504034/
https://www.ncbi.nlm.nih.gov/pubmed/36145676
http://dx.doi.org/10.3390/pharmaceutics14091928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504034/
https://www.ncbi.nlm.nih.gov/pubmed/36145676
http://dx.doi.org/10.3390/pharmaceutics14091928

Ejemplares similares